Differences Between APOE Carriers and Non-APOE Carriers on Neurocognitive Tests: Jensen Effects?

Am J Alzheimers Dis Other Demen. 2018 Sep;33(6):353-361. doi: 10.1177/1533317518765895. Epub 2018 Apr 1.

Abstract

Background: Being a carrier of the apolipoprotein E (APOE) ε4 allele is a clear risk factor for development of Alzheimer's disease (AD). On some neurocognitive tests, there are smaller differences between carriers and noncarriers, while other tests show larger differences.

Aims: We explore whether the size of the difference between carriers and noncarriers is a function of how well the tests measure general intelligence, so whether there are Jensen effects.

Methods: We used the method of correlated vectors on 441 Korean older adults at risk for AD and 44 with AD.

Results: Correlations between APOE carriership and test scores ranged from -.05 to .11 (normal), and -.23 to .54 (AD). The differences between carriers and noncarriers were Jensen effects: r = .31 and r = .54, respectively.

Conclusion: A composite neurocognitive score may show a clearer contrast between APOE carriers and noncarriers than a large number of scores of single neurocognitive tests.

Keywords: Alzheimer’s disease; Korea; apolipoprotein E4; neuropsychological tests.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics*
  • Cognitive Dysfunction / genetics*
  • Female
  • Genotype
  • Humans
  • Male
  • Neuropsychological Tests / statistics & numerical data*
  • Republic of Korea
  • Risk Factors

Substances

  • Apolipoprotein E4